ANI Pharmaceuticals Announces Consolidation of Manufacturing Network, Capturing Operational Synergies Post Novitium Acquisition
businesswire.com
news
2022-06-02 00:00:00

June 02, 2022 04:05 PM Eastern Daylight Time BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it intends to cease operations at its Oakville, Ontario, Canada manufacturing plant by first quarter 2023. This action is part of ongoing initiatives to capture operational synergies following the Company's acquisition of Novitium Pharma in November 2021.



ANI remains committed to meeting patient needs and ensuring the continuity of supply of its medicines to patients and customers.
